论文部分内容阅读
由江苏省卫生厅批准、苏州市卫生局主持的新抗凝血药物肝素钙及其注射液于四月二十日在苏州通过鉴定。此药系苏州生物化学制药厂以猪小肠粘膜为原料制得,产品质最主要指标达到或超过英国药典1980年版标准。肝素钙注射液经苏州传染结核病医院、中国人民解放军第100医院、洛阳医专附院、南京钟阜医院、鼓楼医院、苏州第三人民医院六家医院治疗病毒性肝炎232例临床试验,并以肝素钠注射液双盲对照,两组对急性病毒性黄疸型肝炎的退黄总有效率分别为96.5％、94.62％,谷丙转氨酶的恢复总
Approved by the Department of Health of Jiangsu Province, the new anticoagulant heparin calcium and its injection chaired by Suzhou Municipal Health Bureau passed the appraisal in Suzhou on April 20. This medicine is a biochemical pharmaceutical factory in Suzhou pig intestinal mucosa obtained as raw materials, the main indicators of quality of products meet or exceed the British Pharmacopoeia 1980 edition of the standard. Heparin calcium injection by the Suzhou Infectious Tuberculosis Hospital, People’s Liberation Army No. 100 Hospital, Affiliated Hospital of Luoyang Medical College, Nanjing Zhong Fu Hospital, Drum Tower Hospital, Suzhou Third People’s Hospital of the six hospitals in the treatment of viral hepatitis in 232 cases of clinical trials and Heparin sodium injection double-blind control, the two groups of acute viral jaundice hepatitis, the total effective rate of yellowing were 96.5%, 94.62%, total alanine aminotransferase recovery